EUVIMEDEUVIMED entdecken
Crossref

Phenomapping in Atrioventricular Nodal Reentrant Tachycardia: Mechanistic Insights and Therapeutic Implications

Can Hasdemir iD, Umut Kocabaş, Burcu Yağmur iD, Faruk Bulut, Gülden Hakverdi, Mehmet N Orman, Charles Antzelevitch iD

Journal of Cardiovascular Electrophysiology · 2026

DOI: 10.1111/jce.70439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Can Hasdemir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ege University School of Medicine, İzmir, Türkiye. Hauptthemen laut MEDLINE: Tachycardia, Atrioventricular Nodal Reentry, Catheter Ablation, Heart Rate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Traditional classifications of atrioventricular nodal reentrant tachycardia (AVNRT) based on cardiac symptomatology, electrocardiographic findings, and reentrant circuits do not capture the full heterogeneity of AVNRT.

Objective

This study sought to identify distinct phenotypes among patients with AVNRT by using two‐step cluster analysis and to determine differential effects of phenotypes on clinical and procedural outcomes.

Methods

All patients ( n = 305) underwent catheter ablation and ajmaline challenge testing. A two‐step cluster analysis was conducted using 17 demographic/clinical, anthropometric, electrocardiographic, echocardiographic, and anatomic variables.

Results

Three distinct clinically and mechanistically relevant clusters were identified. Cluster 1 (Metabolic/Structural Phenotype, n = 44) patients were characterized by older age of onset of AVNRT (53.5 ± 8.5, 43.5 ± 15, and 24.7 ± 10.5 years, p = 4.9 × 10 −31 ), shorter distance between coronary sinus floor and His bundle potential (22.7 ± 6.1, 24.7 ± 6.8, and 29 ± 7.5 mm, p = 1.3 × 10 −7 ), higher prevalence of “correlated” (diagnosed ≥ 4 years before AVNRT onset) type 2 diabetes (100%, 0%, and 0%, p = 5.9 × 10 −67 ) and “correlated” (diagnosed ≥ 6 years before AVNRT onset) structural heart disease (86.4%, 100%, 0%, p = 3.5 × 10 −62 ) compared to Cluster 2 (Structural Phenotype, n = 78) and Cluster 3 (Anatomic/Genetic Phenotype, n = 183) patients, respectively. Cluster 1 patients had higher prevalence of “pro‐arrhythmia” (new‐onset and/or symptom worsening/intolerance) with anti‐arrhythmic therapy and/or non‐cardiac drugs (74.2%, 46.5%, and 31.6%, p = 1.5 × 10 −4 ), AH prolongation/AV‐VA block (20.5%, 7.7%, and 2.2%, p = 8.9 × 10 −5 ) and aborted ablation (11.4%, 1.3%, and 0%, p = 8.6 × 10 −5 ) during EP study compared to Clusters 2 and 3 patients, respectively.

Conclusion

Phenomapping identified three clinically and mechanistically relevant phenotypes of AVNRT associated with clinical and procedural outcomes, underscoring the considerable heterogeneity of AVNRT and the importance of comorbidities and substrates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, Atrioventricular Nodal ReentryCatheter AblationHeart RateHumansPhenotypeFemaleMiddle AgedMaleElectrocardiographyAdultTreatment OutcomeAction PotentialsRisk FactorsYoung AdultAge of OnsetAjmalineClustering AlgorithmsAnti-Arrhythmia AgentsTime FactorsCluster AnalysisPredictive Value of Tests

Stichwörter der Autor:innen

AV blockBrugada syndromeatrioventricular nodal reentrant tachycardiacluster analysiscoronary sinusdiabetes mellitushypertensionobesityproarrhythmiatriangle of Koch

Substanzen

AjmalineAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Cardiology, Ege University School of Medicine, İzmir, Türkiye.
  • Department of Cardiology, Başkent University İzmir Hospital, İzmir, Türkiye.
  • Department of Cardiology, University of Kyrenia, Kyrenia, Turkish Republic of Northern Cyprus.
  • Department of Biostatistics, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Türkiye.
  • Department of Biostatistics and Medical Informatics, Ege University School of Medicine, İzmir, Türkiye.
  • Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA.

ORCID-Profile: Can Hasdemir, Burcu Yağmur, Charles Antzelevitch

Zitieren

APA

Hasdemir, C., Kocabaş, U., Yağmur, B., Bulut, F., Hakverdi, G., Orman, M. N., & Antzelevitch, C. (2026). Phenomapping in Atrioventricular Nodal Reentrant Tachycardia: Mechanistic Insights and Therapeutic Implications. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70439

Vancouver

Hasdemir C, Kocabaş U, Yağmur B, Bulut F, Hakverdi G, Orman MN, et al. Phenomapping in Atrioventricular Nodal Reentrant Tachycardia: Mechanistic Insights and Therapeutic Implications. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70439

BibTeX
@article{Hasdemir2026,
  author = {Hasdemir, Can and Kocabaş, Umut and Yağmur, Burcu and Bulut, Faruk and Hakverdi, Gülden and Orman, Mehmet N and Antzelevitch, Charles},
  title = {Phenomapping in Atrioventricular Nodal Reentrant Tachycardia: Mechanistic Insights and Therapeutic Implications},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  doi = {10.1111/jce.70439}
}
Kostenlos starten →